[{"Assets_0_Q3_USD":"1669334000.0","CIK":"874716","CommonStockSharesIssued_0_Q3_shares":"104120000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.81","EarningsPerShareBasic_3_Q3_USD":"2.56","EarningsPerShareDiluted_1_Q3_USD":"0.79","EarningsPerShareDiluted_3_Q3_USD":"2.51","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"42180715521.0","MinorityInterest_0_Q3_USD":"231000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"252150000.0","NetIncomeLoss_1_Q3_USD":"70511000.0","NetIncomeLoss_3_Q3_USD":"224887000.0","OfficialName":"IDEXX Laboratories Inc. Common Stock","ProfitLoss_1_Q3_USD":"70514000.0","ProfitLoss_3_Q3_USD":"224979000.0","RevenuesConverted_1_Q3_USD":"491976000.0","RevenuesConverted_3_Q3_USD":"1462937000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"-48391000.0","StockholdersEquity_0_Q3_USD":"-48622000.0","Ticker":"IDXX","TreasuryStockSharesConverted_0_Q3_shares":"16819000.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"89256000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"89735000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"87537000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"87884000.0","filed":"20171031","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"IDEXX LABORATORIES INC \/DE","period":"20170930","qtrs":"0","uom":"USD"}]